Taku Kambayashi
Affiliations: | Immunology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Immunology, Cell BiologyGoogle:
"Taku Kambayashi"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Okumura M, Yokoyama Y, Yoshida T, et al. (2023) The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function. International Immunopharmacology. 125: 111145 |
| Singh BK, Yokoyama Y, Tanaka Y, et al. (2023) Diacylglycerol kinase zeta deficiency attenuates papain-induced type 2 airway inflammation. Cellular Immunology. 104780 |
| Tanaka Y, Yokoyama Y, Kambayashi T. (2023) Skin-derived TSLP stimulates skin migratory dendritic cells to promote the expansion of regulatory T cells. European Journal of Immunology. e2350390 |
| Thacker G, Henry S, Nandi A, et al. (2023) Immature natural killer cells promote progression of triple-negative breast cancer. Science Translational Medicine. 15: eabl4414 |
| Harabuchi S, Khan O, Bassiri H, et al. (2022) Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8 T cell responses during chronic viral infection. Frontiers in Immunology. 13: 1032113 |
| Kambayashi T, Deshpande DA. (2020) The role of diacylglycerol kinases in allergic airway disease. Current Opinion in Pharmacology. 51: 50-58 |
| Utley A, Chavel C, Lightman S, et al. (2020) CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival. Cell Reports. 31: 107815 |
| Pai RL, Japp AS, Gonzalez M, et al. (2020) Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease. Jci Insight. 5 |
| Tanaka Y, Nagai Y, Okumura M, et al. (2020) PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling. Frontiers in Immunology. 11: 621 |
| Arenas DJ, Floess K, Kobrin D, et al. (2020) Increased mTOR activation in idiopathic multicentric Castleman disease. Blood |